| Medical and Health Sciences | Lifetime | 166 | CA 6 | 99.99 |
| Clinical Neurology | Lifetime | 2 | CA 1 | 99.99 |
| Neuroscience of Neurology | Lifetime | 56 | CA 5 | 99.53 |
| Cellular and Molecular Neuroscience | Lifetime | 108 | CA 4 | 99.63 |
| Clinical Psychology | Lifetime | 904 | CA 56 | 98.60 |
| Psychiatry and Mental health | Lifetime | 490 | CA 32 | 98.34 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 858 | CA 30 | 96.81 |
| Rheumatology | Lifetime | 693 | CA 36 | 96.49 |
| Clinical Neurology | 2021-2025 | 16 | CA 2 | 99.58 |
| Neuroscience of Neurology | 2021-2025 | 135 | CA 6 | 92.79 |
| Cellular and Molecular Neuroscience | 2021-2025 | 108 | CA 7 | 91.75 |
| Psychiatry and Mental health | 2021-2025 | 677 | CA 33 | 77.31 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 1 | CA 1 | 99.98 |
| Genetic Neurodegenerative Diseases | Lifetime | 1 | CA 1 | 99.95 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 2 | CA 1 | 99.98 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 2 | CA 1 | 99.98 |
| Neurological and metabolic disorders | Lifetime | 2 | CA 1 | 99.92 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 2 | CA 1 | 99.63 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 8 | CA 1 | 99.68 |
| Neurological diseases and metabolism | Lifetime | 10 | CA 1 | 99.83 |
| Nuclear Receptors and Signaling | Lifetime | 21 | CA 1 | 99.62 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 79 | CA 8 | 99.14 |
| Autism Spectrum Disorder Research | Lifetime | 167 | CA 10 | 98.90 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 91 | CA 7 | 98.98 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 78 | CA 1 | 99.01 |
| Restless Legs Syndrome Research | Lifetime | 33 | CA 3 | 98.78 |
| Neurology and Historical Studies | Lifetime | 58 | CA 4 | 96.64 |
| Alzheimer's disease research and treatments | Lifetime | 734 | CA 27 | 98.18 |
| RNA regulation and disease | Lifetime | 542 | CA 22 | 95.75 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 264 | CA 3 | 93.56 |
| Ginkgo biloba and Cashew Applications | Lifetime | 240 | CA 12 | 91.08 |
| Hereditary Neurological Disorders | Lifetime | 536 | CA 14 | 92.70 |
| Lysosomal Storage Disorders Research | Lifetime | 946 | CA 31 | 92.54 |
| Hallucinations in medical conditions | Lifetime | 424 | CA 12 | 56.07 |
| Neurological diseases and metabolism | 2021-2025 | 2 | CA 1 | 98.81 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 18 | CA 2 | 99.54 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 16 | CA 3 | 99.50 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 53 | CA 4 | 97.10 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 71 | CA 5 | 96.30 |
| Neurological and metabolic disorders | 2021-2025 | 26 | CA 2 | 89.76 |
| Alzheimer's disease research and treatments | 2021-2025 | 505 | CA 20 | 94.52 |
| RNA regulation and disease | 2021-2025 | 220 | CA 6 | 86.12 |
| Autism Spectrum Disorder Research | 2021-2025 | 865 | CA 54 | 88.60 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 120 | CA 6 | 85.51 |
| Lysosomal Storage Disorders Research | 2021-2025 | 820 | CA 22 | 74.35 |
| Hereditary Neurological Disorders | 2021-2025 | 426 | CA 12 | 71.54 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 625 | CA 9 | 65.99 |
| Nuclear Receptors and Signaling | 2021-2025 | 818 | CA 31 | 50.10 |
| Cerebrovascular and genetic disorders | 2021-2025 | 539 | CA 12 | 46.23 |
